EyePoint, Inc. Share Price
EYPTEyePoint, Inc. Stock Performance
Open $17.50 | Prev. Close $16.89 | Circuit Range N/A |
Day Range $16.82 - $17.50 | Year Range $3.91 - $18.92 | Volume 44,830 |
Average Traded $17.01 |
EyePoint, Inc. Share Price Chart
About EyePoint, Inc.
EyePoint Pharmaceuticals, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is DURAVYU, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E that is in pre-clinical development phase for potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.
EyePoint, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Jan-26 | $17.50 | $16.85 | +0.00% |
06-Jan-26 | $17.50 | $16.85 | -3.38% |
05-Jan-26 | $17.32 | $17.44 | -0.17% |
02-Jan-26 | $18.50 | $17.47 | -4.43% |
31-Dec-25 | $17.98 | $18.28 | +2.01% |
30-Dec-25 | $18.23 | $17.92 | -1.54% |
29-Dec-25 | $18.08 | $18.20 | -0.46% |
FAQs on EyePoint, Inc. Share Price
Can I buy EyePoint, Inc. shares in India?
What is the share price of EyePoint, Inc.?
What is the 5 year returns of EyePoint, Inc.?
What are the high & low stock price of EyePoint, Inc. today?
What is the 52-week high and low of EyePoint, Inc. stock?